Question: Is it lawful for a pharmacist to legally substitute a prescribed branded medication with a cheaper generic equivalent purely to reduce cost, without first obtaining the prescribing doctor’s written approval? Does such substitution expose the pharmacist or hospital to legal liability?
Case Scenario
A patient in Lagos presents a prescription specifying a branded antihypertensive medication. The hospital pharmacy does not have the brand in stock but has an approved generic equivalent at a significantly lower price. To save cost and avoid delaying treatment, the pharmacist dispenses the generic drug without contacting the prescribing doctor.
The patient later complains that the substitution was unauthorised and threatens legal action, alleging deviation from the doctor’s prescription. The hospital argues that the generic drug is therapeutically equivalent and approved by regulators.
Legal perspective
Under Nigerian healthcare law and professional regulation, the pharmacist’s primary duty is to dispense medications safely, accurately, and in accordance with both the prescription and accepted professional standards. The legality of substitution depends on several factors:
Prescription authority – A prescription represents a clinical judgment. Altering it without authorisation may be deemed to exceed professional boundaries unless substitution is permitted by regulation or consent.
Therapeutic equivalence – Generic medicines approved by regulatory authorities are deemed bioequivalent to branded versions. Substitution for cost reasons is not inherently unlawful when safety and efficacy are preserved.
Professional guidelines – Pharmacists are guided by ethical and professional standards encouraging patient-centred care, transparency, and collaboration with prescribers.
Patient consent – Substitution without informing the patient may raise issues of autonomy and informed consent.
Regulatory oversight – Drug regulation frameworks recognise generics as lawful alternatives, but substitution practices should not undermine prescriber authority or patient safety.
Courts would generally examine whether the substitution was reasonable, professionally justified, and transparently handled.
Determining liability
When disputes arise, liability is assessed by examining:
- Clinical justification: Whether the generic was therapeutically equivalent and appropriate.
- Communication: Whether the pharmacist informed the patient and attempted to notify the prescriber.
- Documentation: Records showing rationale for substitution.
- Professional standards: Compliance with accepted pharmacy practice.
- Patient outcome: Whether harm or adverse reaction occurred.
A pharmacist acting in good faith, within professional standards, and without causing harm is less likely to face liability. Conversely, silent substitution that disregards clinical instruction may be considered professional misconduct.
Defences available to pharmacists and healthcare providers
Therapeutic equivalence: The substituted drug met regulatory approval and safety standards.
Good faith practice: The action aimed to ensure continuity of treatment and affordability.
Patient benefit: Substitution prevented delay or financial hardship.
Professional judgment: The decision aligned with pharmacy practice norms.
Absence of harm: No injury resulted from the substitution.
Practical advice
- Establish clear institutional policies on drug substitution.
- Inform patients whenever a substitution is made.
- Where feasible, notify or consult the prescribing doctor.
- Maintain detailed documentation of substitution decisions.
- Educate patients on the safety and equivalence of generics.
Closing insight
Generic substitution can improve affordability and access to care, but it must be balanced with professional accountability and patient trust. Nigerian law does not prohibit therapeutic substitution outright; however, pharmacists must act transparently, document their decisions, and respect prescriber intent. Sound communication and adherence to professional standards remain the strongest safeguards against legal disputes.
